Jenny Johnson, founder of Maritime Inclusion Partners, possesses over 20 years of extensive maritime experience both at sea and ashore. She passionately advocates for a diverse, inclusive ...

Jenny Johnson, president and CEO of Franklin Resources, told analysts on a Jan. 31 earnings call for the quarter ended Dec. 31 that the firm’s Western Asset Management Co. fixed-income affiliate ...

Jenny Johnson is President and CEO of Franklin Templeton. In a career at Franklin Templeton spanning over 30 years, she has been a key driver in the company's transformation to what is now one of ...

New Bears head coach Ben Johnson has been named the assistant coach of the year at NFL Honors in New Orleans. The Bears head coach has the big award for assistant coaches at NFL Honors night..

Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to report fourth-quarter earnings Wednesday morning, with analysts expecting sales and profits to grow year-over-year.

It’s nearly a year and a half since Johnson & Johnson split off its consumer-health arm to focus on pharmaceuticals and medical technology. Johnson & Johnson has wasted no time expanding its ...

Less than 48 hours after their season came to an end, the Lions lost again. On Monday, Ben Johnson decided to leave his post as Detroit's offensive coordinator. He will reportedly stay in the NFC ...

Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...

Supported by operational growth of 6.7%, Johnson & Johnson (JNJ, Financials) reported a 5.3% rise in fourth-quarter revenues to $22.5 billion. With operational growth of 5.9% except for COVID-19 ...

The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Johnson & Johnson (JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to about $143 per share. Several negative impacts were highlighted in the ...